Key statistics
On Friday, Twist Bioscience Corp (0ME:FRA) closed at 39.07, -16.41% below its 52-week high of 46.74, set on Feb 18, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 38.23 |
|---|---|
| High | 39.07 |
| Low | 38.23 |
| Bid | 40.39 |
| Offer | 42.20 |
| Previous close | 41.22 |
| Average volume | 404.70 |
|---|---|
| Shares outstanding | 61.31m |
| Free float | 60.36m |
| P/E (TTM) | -- |
| Market cap | 3.01bn USD |
| EPS (TTM) | -1.27 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 14:25 GMT.
More ▼
Press releases
- Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
- Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
- Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference
- Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
More ▼
